一例垂体后叶素治疗咯血导致低钠血症的病例分析  

A case analysis of hyponatremia caused by posterior pituitary hormone in the treatment of hemoptysis

作　　者：方广 FANG Guang(Pharmaceutical Section,Guangzhou Twelfth People’s Hospital,Guangzhou 510630,China)

机构地区：[1]广州市第十二人民医院药剂科,广州510630

出　　处：《中国处方药》2024年第12期91-93,共3页Journal of China Prescription Drug

摘　　要：目的探讨垂体后叶素引起的低钠血症的临床特点、可能原因及防治策略,为药学监护提供参考及思路。方法临床药师参与1例由垂体后叶素引起的低钠血症的会诊,根据患者的临床体征、检查检验结果及用药情况,分析患者血钠减少的可能原因。结果临床药师认为患者血钠下降很可能为垂体后叶素所致,提出用药建议并参与给药方案的制定等药学监护,协助医师提高药物治疗的安全性及有效性,保证患者的血钠水平平稳回升以及安全续贯的垂体后叶素治疗。结论垂体后叶素致患者低钠血症易被临床忽视,临床药师应警惕该类型的药物不良反应,定期监测患者血钠水平,及时发现药物相关性问题,确保临床用药安全。Objective To explore the clinical characteristics,possible causes,and preventive strategies of hyponatremia induced by posterior pituitary hormone,providing reference and insights for pharmaceutical care.Methods A clinical pharmacist participated in the consultation of a case of hyponatremia caused by posterior pituitary hormone.Based on the patient's clinical signs,examination results,and medication history,the possible reasons for the decrease in blood sodium were analyzed.Results The clinical pharmacist believed that the patient's hyponatremia was likely caused by posterior pituitary hormone,proposed medication suggestions,and participated in pharmaceutical care such as formulating dosing regimens.These measures helped physicians improve the safety and effectiveness of drug therapy,ensuring the stable recovery of the patient's blood sodium level and the safe continuation of posterior pituitary hormone treatment.Conclusion Hyponatremia caused by posterior pituitary hormone may be overlooked clinically,and clinical pharmacists should be vigilant about this type of adverse drug reaction.Regular monitoring of patients'blood sodium levels,timely identification of drug-related issues,and ensuring the safety of clinical drug use are crucial.

关 键 词：垂体后叶素 咯血 低钠血症 药学监护 药品不良反应 

分 类 号：R969[医药卫生—药理学]